Navigation Links
American Chemical Society’s Weekly PressPac -- May 7, 2008
Date:5/12/2008

Vasile, Ph.D.
Romanian Academy
Iasi, Romania
Phone: 40-232-217454
Fax: 40-232-211299
Email: cvasile@icmpp.ro

ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, May 12, 2008

Consumers warm up to greener personal care products, but labeling controversy broils
Chemical & Engineering News

From soaps to body lotions to shampoos, consumers are increasingly drawn to personal care products that are labeled green or environmentally-friendly, a fast-growing market that chalks-up an estimated $4 billion in sales per year worldwide. Despite the hype over these products, theres growing confusion by consumers and manufacturers alike over what it really means to be labeled as green, according to an article scheduled for the May 12 issue of Chemical & Engineering News, ACS weekly newsmagazine.

Written by C&EN Senior Correspondent Marc Reisch, the magazines cover story points out that theres no universal consensus over what is green, organic, or sustainable. To the detriment of consumers, manufacturers sometimes produce misleading labels in an effort to cash-in on the hype, the article notes. Some manufacturers have even begun to certify their products as green under a variety of different standards and criteria or using different certifying bodies.

But change may be around the corner. Some groups in the U.S. and abroad are now working on establishing clearer standards for personal care products. Notes Reisch: Unless ingredient makers and formulators sort out their differences, the subject of what is natural, organic, and sustainable may have to be sorted out in a court of law.

ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, May 12, 2008 Seeking Sustainability

This story will be available on May 12 at http://pubs.acs.org/cen/coverstory/86/8619cover.html


'/>"/>
Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. American Chemical Societys Weekly PressPac -- April 30, 2008
2. Highlights from the May 2008 Journal of the American Dietetic Association
3. US Patent Office rejects companys claim for bean commonly grown by Latin American farmers
4. UMass Medical Schools Craig Mello elected to American Academy of Arts and Sciences
5. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
6. UTSA hosts North American Energy Summit May 1-2
7. American Chemical Societys Weekly PressPac -- April 23, 2008
8. Tips from the Journals of the American Society for Microbiology
9. American College of Medical Genetics makes genetic testing recommendations in new policy statement
10. American Chemical Societys Weekly PressPac -- April 16, 2008
11. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society’s Weekly PressPac -- May 7, 2008
American Chemical Society’s Weekly PressPac -- May 7, 2008
(Date:12/16/2009)... YORK, Dec. 1 iQor, a global provider ... the 2009 InfoWorld 100 Awards Top 100 ... TeQ21. This was the first submission for iQor. ,, ... list of companies," said Vikas Kapoor, president and CEO ... do business, allowing us to work faster, smarter and ...
(Date:12/16/2009)... Dec. 3 BIO-key International, Inc. ... wireless public safety and finger-based biometric identification ... shareholders at a Special Shareholder Meeting held ... Law Enforcement Division to Interact911 Mobile Systems ... cast in favor and 1.2% were opposed. ...
(Date:12/16/2009)... Dec. 9 CSC (NYSE: ... American Association for Laboratory Accreditation awarded the ... 17025:2005 accreditation to the company,s Test Lab, ... Labs located in Fairmont, W.Va. The Test ... in the world to achieve this accomplishment. ...
Breaking Biology News(10 mins):iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7
... of particulate air pollution may increase the risk of ... exposure standards could be insufficient to protect the public. ... exposed to ambient air pollution at the levels observed ... potentially large public health impact," said Lynda Lisabeth, lead ...
... nutrient that dictates productivity (and thus carbon consumption) in ... nitrogen enters the forest through cyanobacteria living on the ... on the forest floor. These bacteria convert nitrogen ... used by other living organisms, a process referred to ...
... demand for and price of oil and other sources ... for abundant, cost-effective alternative sources of energy. One ... is the focus of a new book by ASM ... fuels and the devastating effects of ever-increasing greenhouse gases, ...
Other Biology News:Even low levels of air pollution may pose stroke risk 2Forest canopies help determine natural fertilization rates 2New text highlights role of microorganisms in alternative energy development 2
(Date:12/15/2009)... Thomson Reuters today announced ... first drug pipeline database to fully integrate detailed ... anticipated new content is being provided to all ... Thomson Pharma will offer drug related ... conferences, and other sources across all therapeutic areas. ...
(Date:12/14/2009)... Dec. 14 Array BioPharma Inc. (Nasdaq: ... ) today announced that they entered into an ... small-molecule glucokinase activator program, including ARRY-403, currently being ... patients with Type 2 diabetes. ,, ... receive an upfront payment of $60 million and ...
(Date:12/14/2009)... Rep. Patrick Kennedy Joins with State Biotech ... Leadership in Research and Development while Boosting ... Industry ,, PROVIDENCE, R.I., Dec. 14 ... prominent leaders in research, medicine and biotechnology ... Facility to discuss the importance of medical ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) today announced ... master services agreement with a multi-billion dollar ... serve patients in approximately 100 countries. With ... provider for translation of the company,s online ... resources, legal, and corporate communications information. Lionbridge ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... , , , Includes QIAGEN EZ Competent Cells for added , convenience, , , , ... Component , Included , Concentration , ... , , , ... , 50 ng/l, , ...
... , , For robust amplification in all applications, , , , , , , ... Included , Concentration , , ... , , , , ... 5 units/l , , , ...
... , , , , ... from QIAGEN allows , efficient gene silencing in ... mRNA. This effect, termed RNA interference (RNAi), enables targeted , ... , siRNA oligonucleotide synthesis service that includes a ...
Other Biology Technology:Custom and library siRNA for efficient gene silencing 2Custom and library siRNA for efficient gene silencing 3Custom and library siRNA for efficient gene silencing 4Custom and library siRNA for efficient gene silencing 5